Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reported a transaction involving the withholding of shares for tax purposes related to the vesting of restricted stock.
Summary
- On February 28, 2025, Stephen P. Carey, the SVP & CFO of ANI Pharmaceuticals, had 1,861 shares of common stock withheld for tax purposes.
- The shares were withheld at a price of $61.89 per share.
- This transaction occurred in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported.
- Following the transaction, Carey beneficially owns 192,223 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to tax withholding on vested stock, and doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a standard tax withholding process related to stock vesting.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of the stock transaction (tax withholding) |
| 03/04/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.